• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Oral Squamous Cell Carcinoma

Oral Squamous Cell Carcinoma - 25 Studies Found

Completed : Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell Carcinoma
: Oral Squamous Cell Carcinoma
: 2011-04-06
: Procedure: elective neck dissection patient underwent elective neck dissection as initial treatment, alo
Completed : Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
:
  • Oral Squamous Cell Carcinoma
  • Oral Epithelial Dysplasia
  • : 2013-11-07
Completed : Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma
: Oral Squamous Cell Carcinoma
: 2016-03-22
: Drug: Celecoxib 200 mg of Celecoxib daily for 6-month treatment after surgery within 1 - 6 months
Completed : Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer
: Oral Squamous Cell Carcinoma
: 2012-04-26
: Other: saliva collection prior to clinically driven oral biopsy cell free saliva to be used to measure m
Completed : A Dye for the Detection of Cancer of the Tongue and Mouth
: Oral Squamous Cell Carcinoma (OSCC)
: 2017-03-15
: Drug: Olaparib For PARRi-FL, imaging patients will first gargle a solution of PARRi-FL for 1 min, then s
Not yet recruiting : Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
: Hepatitis C
: 2017-04-03
: Other: oral squamous cell carcinoma Histological diagnosis of H&E stained sections will be performed
Not yet recruiting : The Role of microRNA-29b in the Oral Squamous Cell Carcinoma
: Oral Cancer
: 2013-12-09
Active, not recruiting : One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
: cN0 Oral Squamous Cell Carcinomas
: 2016-07-19
Active, not recruiting : Fluorescent Visualization in Early Oral Cancer
: Oral Squamous Cell Carcinoma or Severe Dysplasia
: 2014-12-01
:
  • Procedure: resection of oral cancer

Active, not recruiting : TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma
:
  • Stage III Oral Cavity Squamous Cell Carcinoma
  • Stage IVA Oral Cavity Squamous Cell Carcinoma<
    : 2012-02-26
    : Drug: TPF induction chemotherapy Docetaxel (at a dose of 75mg/m2 of body surface area) was administered
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.